What's in Bandim Health Project's pipeline?

Bandim Health Project has 11 drugs in our index: 10 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 1 in Phase 1.

Which companies overlap with Bandim Health Project's portfolio?

Top competitors by shared drug class: Centers for Disease Control and Prevention, Institute of Medical Biology, Chinese Academy of Medical Sciences, Beijing Center for Disease Control and Prevention, Canadian Immunization Research Network, Chinese Academy of Medical Sciences.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/bandim-health-project.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Bandim Health Project — Portfolio Competitive Intelligence Brief

Bandim Health Project pipeline: 10 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

10 marketed 0 filed 0 Phase 3 0 Phase 2 1 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Early measles vaccine	Early measles vaccine	marketed
BCG-Russia	BCG-Russia	marketed
BCG-Denmark	BCG-Denmark	marketed
Bacille Calmette Guerin (BCG)	Bacille Calmette Guerin (BCG)	marketed	Live attenuated vaccine		Immunology, Oncology, Infectious Disease
BCG-Japan	BCG-Japan	marketed
Measles and inactivated polio vaccine	Measles and inactivated polio vaccine	marketed	vaccine		Immunology
Measles vaccine	Measles vaccine	marketed	Live attenuated vaccine	Measles virus surface glycoproteins (H and F proteins)	Immunology / Infectious Disease
BCG solvent	BCG solvent	marketed	Live attenuated vaccine		Immunology; Infectious Disease
BCG-Bulgaria	BCG-Bulgaria	marketed	Live attenuated vaccine		Immunology / Infectious Disease
oral polio vaccine + information	oral polio vaccine + information	marketed	Live attenuated vaccine	Poliovirus types 1, 2, and 3	Immunology / Infectious Disease

Therapeutic area mix

Immunology / Infectious Disease · 3
Immunology · 1
Immunology, Oncology, Infectious Disease · 1
Immunology; Infectious Disease · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Centers for Disease Control and Prevention · 2 shared drug classes
Institute of Medical Biology, Chinese Academy of Medical Sciences · 2 shared drug classes
Beijing Center for Disease Control and Prevention · 2 shared drug classes
Canadian Immunization Research Network · 2 shared drug classes
Chinese Academy of Medical Sciences · 2 shared drug classes
GlaxoSmithKline · 2 shared drug classes
Aga Khan University · 2 shared drug classes
International Centre for Diarrhoeal Disease Research, Bangladesh · 2 shared drug classes

Subscribe to ongoing alerts

Every new pipeline event for Bandim Health Project:

Cite this brief

Drug Landscape (2026). Bandim Health Project — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/bandim-health-project. Accessed 2026-05-16.